Evogene Schedules Third Quarter 2024 Financial Results Release
Evogene Schedules Third Quarter 2024 Financial Results Release
To join the conference, please register in advance:Zoom conference call scheduled for November 21, 2024, 9:00 AM ET
Zoom视频会议已安排在2024年11月21日上午9点（美国东部时间）
REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter of 2024, on Thursday, November 21, 2024.
以色列REHOVOT，2024年11月7日 / PRNewswire / - evogene公司（纳斯达克：evogene）（TASE：evogene），一家领先的计算生物学公司，旨在革新生命科学产品的发现和开发，今天宣布将于2024年11月21日星期四发布2024年第三季度财务业绩。
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
当天晚些时候，公司管理团队将在东部时间上午9点（以色列时间下午4点）举行电话会议讨论业绩。
To join the conference, please register in advance:
要参加会议，请提前注册：
The entire conference will be available online on the company's website a few days after.
整个会议将几天后在公司网站上线。
About Evogene:
关于Evogene：
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene Ltd. (纳斯达克: EVGN，特拉维夫证券交易所: EVGN)是一家计算生物学公司，利用大数据和人工智能，旨在通过利用先进技术来提高成功率、缩短开发时间和降低成本，从而彻底改变基于生命科学的产品开发。
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene建立了三个独特的技术引擎——MicroBoost AI、ChemPass AI和GeneRator AI。每个技术引擎都专注于基于以下核心元素之一的产品的发现和开发：微生物（MicroBoost AI）、小分子（ChemPass AI）和基因元件（GeneRator AI）。
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
evogene利用其技术引擎通过战略合作伙伴关系和合作开发产品，旗下有四个子公司，包括：
- Biomica Ltd. () - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
- Lavie Bio Ltd. () - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
- AgPlenus Ltd. () - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
- Casterra Ag Ltd. () - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.
- Biomica有限公司() - 开发和推进新型基于微生物组的治疗方法，以MicroBoost AI为支持。
- Lavie Bio有限公司() - 开发和商业推进，基于微生物组的农业生物制品，由MicroBoost AI提供支持。
- AgPlenus有限公司() - 开发下一代高效可持续作物保护的农业化学品，由ChemPass AI提供支持。
- Casterra Ag有限公司() - 开发和推广优质蓖麻籽品种，产量高且油质优良，在工业规模上为生物燃料和其他行业提供支持，由GeneRator 人工智能提供支持。
For more information, please visit: .
欲了解更多信息，请访问:
Logo -
Logo -
Contact
[email protected]
Tel: +972-8-9311901
联系方式
[email protected]
电话：+972-8-9311901
SOURCE Evogene
Evogene信息来源
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗？
译文内容由第三方软件翻译。
